Presentation is loading. Please wait.

Presentation is loading. Please wait.

When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study  Uzi Izhar,

Similar presentations


Presentation on theme: "When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study  Uzi Izhar,"— Presentation transcript:

1 When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study  Uzi Izhar, MD, Niv Ad, MD, Ehud Rudis, MD, Eli Milgalter, MD, Amit Korach, MD, Nicola Viola, MD, Eli Levi, MD, Galit Asraff, RN, BSN, Gideon Merin, MD, Amir Elami, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 129, Issue 2, Pages (February 2005) DOI: /j.jtcvs Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Study population. AF, Atrial fibrillation; CABG, coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study  Uzi Izhar,"

Similar presentations


Ads by Google